drugset / Trial / NCT05165914

Midazolam Effect on Agitation Postnasal Surgery

NCT05165914 ↗

Completed 100 enrolled Jordanian Royal Medical Services
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Postoperative agitation is a common complication, it's incidence post head and neck surgery is around 11-26%. Avoiding such complication is mandatory to facilitate patient's recovery and reduce risk of postoperative agitation related complications. Our study aims to detect the incidence of agitation following nasal surgery, and to determine the midazolam effect on agitation, when administered just before emergence from anesthesia.

Timeline

Start
2021-05-27
Primary completion
2021-11-25
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 0.03 mg/kg Intravenous

Indications

No indication recorded.